Molecular identification of sex in Simarouba glauca by RAPD markers for crop improvement strategies. [PDF]
Biotechnol Rep (Amst), 2014 Due to lack of morphological methods to identify sex at early stage in the plants with long juvenile period the application of molecular markers is expected to facilitate breeding program.
Vaidya G, Naik GR.
europepmc +4 more sources
Oral acute and sub-chronic toxicity assessment of aqueous leaf extract of Simarouba glauca DC (Paradise tree). [PDF]
Toxicol Rep, 2021 Simarouba glauca has been widely reported to be effective against a number of diseases and possesses medicinal benefits. Thus, the study was conducted to evaluate the toxic effect of aqueous leaf extract of Simarouba glauca (AESG) on relevant organs of ...
Osagie-Eweka SE +3 more
europepmc +2 more sources
Broad-Spectrum Antimicrobial, Antioxidant, and Anticancer Studies of Leaf Extract of Simarouba glauca DC In Vitro. [PDF]
Antibiotics (Basel), 2022 The current study aimed to screen the preliminary phytochemicals in the leaf extract of the medicinal plant Simarouba glauca and to analyze its potential antimicrobial, antioxidant and anticancer properties.
Ramasamy SP +11 more
europepmc +2 more sources
Safety evaluation of Simarouba glauca seed fat. [PDF]
J Food Sci Technol, 2014 Simarouba glauca DC is a tree of the family Simaroubaceae, which grows well up to 1,000 m above sea level in all types of well-drained soils (pH 5.5 to 8.0) and in places with 250 to 2,500 mm annual rainfall. The seed oil has been extracted both by mechanical expelling and solvent extraction.
Rout PK +4 more
europepmc +4 more sources
Alpha glucosidase inhibition activity of phenolic fraction from Simarouba glauca: An in-vitro, in-silico and kinetic study. [PDF]
Heliyon, 2020 A phenolic rich fraction purified from Simarouba glauca leaves was effective in alpha glucosidase inhibition. The purified fraction named ‘fraction-14’ had shown significant inhibition of yeast alpha glucosidase enzyme activity (IC50 = 2.4 ± 0.4 μg/mL ...
Mugaranja KP, Kulal A.
europepmc +2 more sources
Anti-proliferative potential of phytochemical fractions isolated from Simarouba glauca DC leaf. [PDF]
Heliyon, 2020 Emerging advancements in anticancer drug discovery research are leaning towards the plant-based bioactive fractions, which is a cocktail of naturally abundant two or more substances with unique proportions, exhibiting greater potential to combat cancers ...
Jose A, Kannan E, Madhunapantula SV.
europepmc +2 more sources
Medicinal Potential of Laxmi Taru (Simarouba Glauca DC)
Dev Sanskriti: Interdisciplinary International Journal, 2021 Cancer is becoming a high-profile disease throughout the world and for its treatment most prevalent technique is chemotherapy which has its limitations due to many toxic or side effects on healthy or non-cancerous body parts.
Lalit Raj Singh, Sunita Garg
doaj +3 more sources
Bioactivity-Guided Fractionation, Characterization, and Mechanistic Insights of Anticancer Agents from <i>Simarouba glauca</i> DC. Leaves. [PDF]
MoleculesAlthough Simarouba glauca DC. has been recognized for its therapeutic properties, its anticancer effects against oral cancer have not been adequately investigated. The present study aimed to evaluate the activity of S.
Rudraswamy S +4 more
europepmc +2 more sources
In Vitro Antiviral Activity of Potential Medicinal Plant Extracts Against Dengue and Chikungunya Viruses. [PDF]
Front Cell Infect Microbiol, 2022 Dengue and chikungunya are two important mosquito-borne infections which are known to occur extensively in tropical and subtropical areas. Presently, there is no treatment for these viral diseases.
Alagarasu K +9 more
europepmc +2 more sources
Tricaproin Isolated From Simarouba glauca Inhibits the Growth of Human Colorectal Carcinoma Cell Lines by Targeting Class-1 Histone Deacetylases. [PDF]
Front Pharmacol, 2018 While anticancer properties of Simarouba glauca (SG, commonly known as Paradise tree) are well documented in ancient literature, the underlying mechanisms leading to cancer cell death begin to emerge very recently.
Jose A +3 more
europepmc +2 more sources